Clinical Trial Update: The UTHealth Ketamine Project [Phase 2]

View source ↗

Summary

Phase 2 trial update for the UTHealth Ketamine Project in treatment-resistant depression and major depressive disorder (terminated with results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2020-11-09